Spero Therapeutics, Inc.

SPRO · XNAS

CIK 1701108fmd_0FYRTHTNVEFZ5HQ2KJZXNCDK2DManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2015 to Sep 30, 2026, 44 periods

Ratios computed from the standardized statements. Select a value to open its proof.